Last reviewed · How we verify
NCT04994184
Scoring System in Predicting Perforated Duodenal Ulcer Morbidity and Mortality in Bpkihs
trial in Perforated Duodenal Ulcer in 74 participants. Completed in 1 July 2021.
30 June 2021
Quick facts
| Lead sponsor | B.P. Koirala Institute of Health Sciences |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 74 |
| Start date | 25 March 2021 |
| Primary completion | 30 June 2021 |
| Estimated completion | 1 July 2021 |
| Sites | 1 location across Nepal |
Conditions studied
- Perforated Duodenal Ulcer — all drugs for Perforated Duodenal Ulcer →
Sponsor
B.P. Koirala Institute of Health Sciences
Who can join
Adults 16 to 80, any sex, with Perforated Duodenal Ulcer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Different scoring systems were developed for risk prediction and adjustment of morbidity from perforated duodenal ulcer. However, these scoring systems are not routinely used in perforated duodenal ulcer patient in everyday clinical practice. Identification of patient with a high risk of adverse outcomes following surgery is important for clinical decision-making which can assist in risk stratification and triage e.g. timing and extent of pre-operative respiratory and circulatory stabilization, postoperative admission to a high dependency unit (HDU), the level and extent of monitoring, and inclusion in specific perioperative care protocols. Few studies assessed and compared the accuracy indices of PULP with BOEY and ASA in predicting post PPU repair 30-day morbidity Further, the efficacy must be verified in individual settings like ours. So we wish to assess its efficacy in BPKIHS-a tertiary referral center of eastern Nepal.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04994184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other B.P. Koirala Institute of Health Sciences trials
Trials by the same sponsor.
- NCT07285447 — Re-use of Ambu aScope During Exploration of the Common Bile Duct for Stones in Low-Resource Settings- a Retrospective St · completed
- NCT06713733 — Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative · NA · recruiting
- NCT07003581 — Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis · completed
- NCT06146491 — A COMPARISON OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMEN · Phase 4 · unknown
- NCT07378462 — A Retrospective Randomized Controlled Study Comparing the Effectiveness of Low-level Laser Therapy and Ultrasound Therap · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04994184 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by B.P. Koirala Institute of Health Sciences
- Last refreshed: 9 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04994184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing